In pancreatic ductal adenocarcinoma, increased PRMT1 expression correlates with GLI1 expression and leads to SMO-independent GLI1 activation, thereby mediating its oncogenic functions. The gene discussed is GLI1; the disease is pancreatic ductal adenocarcinoma.